Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1980 2
1981 2
1984 1
1986 2
1987 5
1988 9
1989 9
1990 8
1991 10
1992 1
1993 2
1994 3
1995 1
1996 3
1997 5
1998 1
2000 4
2001 1
2002 1
2003 4
2004 1
2005 3
2006 5
2007 5
2008 3
2009 5
2010 6
2011 9
2012 8
2013 6
2014 8
2015 6
2016 11
2017 6
2018 11
2019 5
2020 7
2021 8
2022 2
2023 7
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Results by year

Filters applied: . Clear all
Page 1
Mesenteric Volvulus from Jejunal Diverticulosis.
Hung WY, Huang CY. Hung WY, et al. N Engl J Med. 2020 Jun 25;382(26):e106. doi: 10.1056/NEJMicm1911732. N Engl J Med. 2020. PMID: 32579816 No abstract available.
A Survey of the Regulatory Requirements for BCS-Based Biowaivers for Solid Oral Dosage Forms by Participating Regulators and Organisations of the International Generic Drug Regulators Programme.
Van Oudtshoorn JE, García-Arieta A, Santos GML, Crane C, Rodrigues C, Simon C, Kim JM, Park SA, Okada Y, Kuribayashi R, Pfäffli C, Nolting A, Lojero IOC, Martínez ZR, Hung WY, Braddy AC, Leal NA, Triana DG, Clarke M, Bachmann P. Van Oudtshoorn JE, et al. Among authors: hung wy. J Pharm Pharm Sci. 2018;21(1):27-37. doi: 10.18433/J3X93K. J Pharm Pharm Sci. 2018. PMID: 29382433 Free article. Review.
Requirements for Additional Strength Biowaivers for Modified Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities.
Roost MS, Potthast H, Walther C, García-Arieta A, Abalos I, Agostinho Freitas Fernandes E, Mendes Lima Santos G, Rodríguez Martínez Z, Tam A, Rodrigues C, Gutierrez Triana DA, Guzmán Aurela E, Rodríguez Rodríguez N, Aeh Park S, Kim J, Kariv R, Divinsky M, Jones B, Kuribayashi R, Myoenzono A, Kasuga M, Van Oudtshoorn J, Chi JF, Hung WY, Hsu LF, Crane C, Jarman T, Braddy A. Roost MS, et al. Among authors: hung wy. J Pharm Pharm Sci. 2021;24:548-562. doi: 10.18433/jpps32260. J Pharm Pharm Sci. 2021. PMID: 34706215 Free article. Review.
190 results